Schertz Bergmann Rechtsanwälte: Alexander Zverev
As lawyers for Alexander Zverev, we declare on behalf of our client that the criminal proceedings under file number 250 Cs 184/23 have been dropped.
The criminal proceedings against Alexander Zverev were dropped and the case was terminated today by the court with the consent of the public prosecutor's office, Ms. Brenda Patea as joint plaintiff and Alexander Zverev's defence lawyer. The penalty order is now groundless.
Alexander Zverev has agreed to this discontinuation via his defense lawyer, solely in order to shorten the proceedings - above all in the interests of their child. Alexander Zverev is considered innocent. The dismissal does not constitute a finding of guilt or an admission of guilt. The legal presumption of innocence remains unaffected.
Dr. Anna Sophie Heuchemer (Schertz Bergmann Attorneys at law)
Katharina Dierlamm (Dierlamm Attorneys at law)
Pressekontakt
Schertz Bergmann Rechtsanwälte PartG mbB
Kurfürstendamm 53
10707 Berlin
Tel.: 030 88 00 150
E-Mail:cs@schertz-bergmann.de
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Successor to the emporia bestseller: The smartphone that fits in every pocket25.7.2024 08:05:00 CEST | Press release
(Linz, Austria). The European smartphone company emporia is launching the successor to its previous bestseller on the market for the past 2 years. The emporiaSMART.6lite follows on from the emporiaSMART.5 - which has been voted “senior smartphone of the year” in Germany three times in a row.
37th Maschsee Festival in Hannover begins at the end of July and promises 19 days of maritime open-air flair in the heart of the city24.7.2024 13:38:07 CEST | Press release
On 31 July Maschsee Festival in Hannover will kick off for the 37th time. For 19 days – until 18 August – the capital city of Lower Saxony will host Germany’s largest lakeside festival on and around the water.
Gerhard Burits takes on new role at the ELATEC Group / RFID specialist ELATEC: New management duo with many years of experience23.7.2024 09:00:00 CEST | Press release
Munich, July 23, 2024 – Gerhard Burits expands his responsibilities and assumes the role of CEO of the ELATEC Group. Thanks to his in-depth knowledge of the company structure and his strategic foresight, he is ideally qualified to reinforce ELATEC’s position as an innovation leader in global competition. The management board will have joint leaders at the helm: Also on board is Paul Massey, who, as CEO of ELATEC Inc., is now also taking on the role of COO of the ELATEC Group and contributing his international expertise to a greater extent. Gerhard Burits, who joined the company in June 2020 as Chief Financial Officer (CFO), has been appointed Chief Executive Officer (CEO) of ELATEC GmbH. Over the past four years, he has made a significant contribution as CFO to financial stability and international growth, positioning ELATEC excellently with his strategic expertise. As CEO, he is now determined to reinforce the ELATEC Group’s technological lead, strengthen its presence on the global ma
Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®22.7.2024 10:05:22 CEST | Press release
Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly strengthening its profitability. Aachen, Germany, 22 July 2024 – Grünenthal today announced the acquisition of US-based Valinor Pharma, LLC (“Valinor”) and its product Movantik® (naloxegol), with a total deal value of approx. $250 million inclusive of all royalty obligations. Grünenthal will finance the transaction using available liquidity. Movantik® is indicated for the oral treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. The transaction further expands Grünenthal’s portfolio of established medicines and adds to the company’s growing U.S. business. Gross sales from Movantik® in the United States reached over $200 m
FitLine becomes Official Partner of the ATP Tour18.7.2024 09:05:20 CEST | Press release
(London/Schengen, July 18th, 2024) FitLine is proud to announce a new multi-year partnership with the world’s top-tier men’s tennis tour. The athletes will benefit from the FitLine products, with the brand being the new Official Sports Nutrition Partner and Official Energy Bar Partner of the ATP Tour. The ATP Tour chose FitLine as its new Official Partner due to the shared commitment to supporting athletic performance and clean sport, both for professional and recreational athletes alike. “We’re delighted to welcome Fitline to the ATP Tour’s partner roster. The synergies between our brands are evident, with both organisations dedicated to optimising athletic performance”, said Massimo Calvelli, ATP CEO. “This partnership reflects the ATP Tour's appeal to global partners and our strength in engaging fans digitally.” FitLine’s premium products are developed and distributed exclusively by PM-International. CEO, Rolf Sorg, added, “Through our partnership with the ATP Tour, we are proud tha
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom